Sevoflurane	B:C0087111
postconditioning	I:C0087111
improves	B:C0184511
myocardial	B:C0027061
mitochondrial	B:C0026237
respiratory	B:C0282636
function	I:C0282636
and	O
reduces	O
myocardial	B:C0151744
ischemia	I:C0151744
-	O
reperfusion	B:C0035126
injury	I:C0035126
by	O
up	B:C0041904
-	I:C0041904
regulating	I:C0041904
hypoxia	B:C0215848
-	I:C0215848
inducible	I:C0215848
factor	I:C0215848
-	I:C0215848
1	I:C0215848
.	O
Sevoflurane	B:C0087111
postconditioning	I:C0087111
(	O
Sevoflurane	B:C0087111
postconditioning	I:C0087111
)	O
can	O
exert	O
myocardial	B:C0027061
protective	O
effects	O
similar	O
to	O
ischemic	B:C2936234
preconditioning	I:C2936234
.	O

However	O
,	O
the	O
exact	O
myocardial	B:C0027061
protection	O
mechanism	O
by	O
Sevoflurane	B:C0087111
postconditioning	I:C0087111
is	O
unclear	O
.	O

Studies	B:C2603343
indicate	O
that	O
hypoxia	B:C0215848
-	I:C0215848
inducible	I:C0215848
factor	I:C0215848
-	I:C0215848
1	I:C0215848
(	O
hypoxia	B:C0215848
-	I:C0215848
inducible	I:C0215848
factor	I:C0215848
-	I:C0215848
1	I:C0215848
)	O
maintains	O
cellular	B:C0282636
respiration	I:C0282636
homeostasis	B:C0019868
by	O
regulating	O
mitochondrial	B:C0026237
respiratory	B:C0162362
chain	I:C0162362
enzyme	B:C0243102
activity	I:C0243102
under	O
hypoxic	B:C0242184
conditions	I:C0242184
.	O

This	O
study	B:C2603343
investigated	O
whether	O
Sevoflurane	B:C0087111
postconditioning	I:C0087111
could	O
regulate	O
the	O
expression	B:C1171362
of	O
myocardial	B:C0027061
HIF	B:C0965644
-	I:C0965644
1α	I:C0965644
and	O
to	O
improve	B:C0184511
mitochondrial	B:C0026237
respiratory	B:C0282636
function	I:C0282636
,	O
thereby	O
relieving	O
myocardial	B:C0151744
ischemia	I:C0151744
-	O
reperfusion	B:C0035126
injury	I:C0035126
in	O
rats	B:C0034721
.	O

The	O
myocardial	B:C0151744
ischemia	I:C0151744
-	O
reperfusion	B:C0035126
rat	B:C0034721
model	B:C0599779
was	O
established	O
using	O
the	O
Langendorff	B:C4042864
isolated	I:C4042864
heart	I:C4042864
perfusion	I:C4042864
apparatus	I:C4042864
.	O

Additionally	O
,	O
postconditioning	B:C0087111
was	O
performed	O
using	O
sevoflurane	B:C0074414
alone	O
or	O
in	O
combination	O
with	O
the	O
HIF	B:C0965644
-	I:C0965644
1α	I:C0965644
inhibitor	O
2	B:C0046319
-	I:C0046319
methoxyestradiol	I:C0046319
(	O
2ME2	B:C0046319
)	O
.	O

The	O
changes	O
in	O
hemodynamic	B:C0019010
parameters	O
,	O
HIF	B:C0965644
-	I:C0965644
1α	I:C0965644
protein	B:C1171362
expression	I:C1171362
levels	O
,	O
mitochondrial	B:C0026237
respiratory	B:C0282636
function	I:C0282636
and	O
enzyme	B:C0243102
activity	I:C0243102
,	O
mitochondrial	B:C0026237
reactive	B:C0162772
oxygen	I:C0162772
species	I:C0162772
(	O
reactive	B:C0162772
oxygen	I:C0162772
species	I:C0162772
)	O
production	B:C0220781
rates	O
,	O
and	O
mitochondrial	B:C0026237
ultrastructure	O
were	O
measured	O
or	O
observed	O
.	O

Compared	O
to	O
the	O
ischemia	B:C0151744
-	O
reperfusion	B:C0035126
(	O
I	B:C0151744
/	O
R	B:C0035126
)	O
group	O
,	O
HIF	B:C0965644
-	I:C0965644
1α	I:C0965644
expression	B:C1171362
in	O
the	O
Sevoflurane	B:C0087111
postconditioning	I:C0087111
group	O
was	O
significantly	O
up	B:C0041904
-	I:C0041904
regulated	I:C0041904
.	O

Additionally	O
,	O
cardiac	B:C0232164
function	I:C0232164
indicators	O
,	O
mitochondrial	B:C0026237
state	B:C0282636
3	I:C0282636
respiratory	I:C0282636
rate	O
,	O
respiratory	O
control	O
ratio	O
(	O
RCR	O
)	O
,	O
cytochrome	B:C0010760
C	I:C0010760
oxidase	I:C0010760
(	O
cytochrome	B:C0010760
C	I:C0010760
oxidase	I:C0010760
)	O
,	O
NADH	B:C0131722
oxidase	I:C0131722
(	O
NADH	B:C0131722
oxidase	I:C0131722
)	O
,	O
and	O
succinate	B:C0075423
oxidase	I:C0075423
(	O
succinate	B:C0075423
oxidase	I:C0075423
)	O
activities	B:C0243102
,	O
mitochondrial	B:C0026237
reactive	B:C0162772
oxygen	I:C0162772
species	I:C0162772
production	B:C0220781
rate	O
,	O
and	O
mitochondrial	B:C0026237
ultrastructure	O
were	O
significantly	O
better	O
than	O
those	O
in	O
the	O
I	B:C0151744
/	O
R	B:C0035126
group	O
.	O

However	O
,	O
these	O
advantages	O
were	O
completely	O
reversed	O
by	O
the	O
HIF	B:C0965644
-	I:C0965644
1α	I:C0965644
specific	O
inhibitor	O
2ME2	B:C0046319
(	O
P<	O
0.05	O
)	O
.	O

The	O
myocardial	B:C0027061
protective	O
function	O
of	O
Sevoflurane	B:C0087111
postconditioning	I:C0087111
might	O
be	O
associated	O
with	O
the	O
improvement	O
of	O
mitochondrial	B:C0026237
respiratory	B:C0282636
function	I:C0282636
after	O
up	O
-	O
regulation	O
of	O
HIF	B:C0965644
-	I:C0965644
1α	I:C0965644
expression	B:C1171362
.	O

